Metraipolis › archive › dc_e45bd7591ea3

Scleromyxedema Managed With High-Dose Intravenous Immunoglobulin and Bortezomib-Dexamethasone: A Case Report — Europe PMC PMID:41766765

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41766765
DOI: 10.1155/crom/3773160
License (as archived): solo-consultazione
Archived: 2026-11-05T10:12:10.950Z
SHA-256 of the archived text: 9024b8c8134d6b07b0d9c11227583737ad343055786f34a895e8c4bca580667d
Stable URL of this page: https://metraipolis.com/documento/dc_e45bd7591ea3

How to cite

Scleromyxedema Managed With High-Dose Intravenous Immunoglobulin and Bortezomib-Dexamethasone: A Case Report — Europe PMC PMID:41766765 — Europe PMC (en), https://europepmc.org/article/MED/41766765 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e45bd7591ea3 (Metraipolis archive dc_e45bd7591ea3, sha256 9024b8c8134d6b07b0d9c11227583737ad343055786f34a895e8c4bca580667d)

BibTeX

@misc{dce45bd7591ea3,
  title = {Scleromyxedema Managed With High-Dose Intravenous Immunoglobulin and Bortezomib-Dexamethasone: A Case Report — Europe PMC PMID:41766765},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41766765},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e45bd7591ea3; sha256 9024b8c8134d6b07b0d9c11227583737ad343055786f34a895e8c4bca580667d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41766765. Agents can read the archived copy with the MCP tool read_document.